To compare the sensitivity and suitability of detection of active cytomegalovirus (CMV) infection by using monoclonal antibodies against CMV antigen (antigen test to detect antigenemia) and the polymerase chain reaction (PCR; to detect viral DNA) in granulocytes, 19 heart and 2 lung transplant recipients were closely monitored by these tests for at least 3 months after transplantation. All patients were CMV seropositive or had a seropositive donor. In total, 201 samples were tested; 46 were positive by both tests, 9 samples showed only antigenemia, 54 samples were positive by PCR only, and 102 samples were negative by both tests. PCR was positive earlier after transplantation in eight patients, whereas antigenemia was positive earlier after transplantation in one patient. In another four patients, both tests were positive at the same time. PCR was, on average, positive for a longer period of time. Discordant results showing a positive antigen test and a negative PCR were partly due to sampling error; some were positive by PCR on retesting. Samples which were negative by the antigen test and positive by PCR were taken at the beginning or at the end of an active CMV infection. In two patients, no active CMV infection was detected by the antigen test, cultures of urine and saliva, or serology, although PCR was positive for a long period of time in the two patients.
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Recently, two new rapid tests for early detection of active cytomegalovirus (CMV) infection have been developed. These tests are detection of CMV antigen in peripheral blood leukocytes with monoclonal antibodies (antigen test; a positive result is defined as antigenemia) and detection of CMV DNA by the polymerase chain reaction (PCR).
The value of the antigen test has been investigated in kidney (1, 9) and heart transplant (10) recipients and proved to be suitable for the early detection of active infection (1, 10). Also, high-level antigenemia was found to be related to symptomatic infection (9) .
Detection of CMV DNA in peripheral blood by PCR has been investigated in kidney (5) and bone marrow (2, 4) transplant recipients. PCR also proved to be an early indicator of active CMV infection and was found to be more sensitive than culture of CMV from buffy coat cells (4, 5) . PCR has also been applied to tissue specimens for the detection of CMV DNA in biopsy specimens taken from patients with CMV disease and proved to be more sensitive than in situ hybridization and slot blot hybridization with probes (4) .
To compare the abilities of the CMV antigen and CMV DNA PCR methods to detect CMV infections in peripheral blood, both tests should be applied on the same samples. We performed both tests on peripheral blood granulocytes, since these cells appear to express CMV more readily than do monocytes and lymphocytes (3, 8) . The serology, which test is most suitable for the early detection of active CMV infection and the detection of CMV disease.
MATERIALS AND METHODS
Patients. Blood samples were obtained weekly or biweekly from 19 heart and 2 lung transplant recipients. The CMV carrier status of donors and recipients was determined by the detection of anti-CMV immunoglobulin G (IgG) and IgM antibodies by an enzyme-linked immunosorbent assay (ELISA; Sorin Biomedica, Saluggia, Italy). Both lung transplant recipients were CMV positive; one of the patients had a CMV-negative donor and one had a CMV-positive donor. Of the 14 CMV-seropositive heart transplant recipients, 5 had CMV-positive donors, 6 had CMV-negative donors, and 3 had donors with unknown CMV serologies. Another five heart transplant recipients were CMV negative and had CMV-positive donors; primary CMV infections, as determined by the presence of IgM anti-CMV antibodies in serum, occurred in four of these patients.
For detection of antigenemia and CMV DNA by PCR, 5 PCR. The granulocytes isolated from the blood samples were stored in methanol at -20°C until use. Before PCR, the methanol was removed by centrifugation and evaporation. Pretreatment of the samples consisted of overnight incubation with proteinase K (Boehringer, Mannheim, Germany) (a 200-,ug/ml solution of proteinase K containing 0.25% Tween 20; 37°C). For amplification, two primers were used (5' primer sequence, 5'-TGC TCA CGC ACA TTG ATC AC-3'; 3' primer sequence, 5'-GTA CTG GGC AAA GAC CTT CA-3'), both of which were located within the fourth exon of the CMV immediate-early gene, resulting in a 273-bp DNA fragment after amplification.
Samples were denatured at 100°C for 10 min and after that they were specifically amplified in a 50-pI reaction mixture containing 5 RI of sample, 11.1 mM Tris-HCl, 11.1 mM MgCl2, 55.6 mM NaCl, 4 mM deoxynucleoside triphosphates (Boehringer), 0.25 ,ug of each primer, and 0.5 U of ampli-Taq polymerase (Cetus, Norwalk, Conn.). Each sample was amplified in 35 cycles of 95, 60, and 72°C in a thermal cycler (Perkin-Elmer Cetus, Gouda, The Netherlands).
As a positive control for the presence of sufficient DNA from each sample, amplification of the 3-globin DNA was also performed at the same time (7). Procedures for avoiding contamination were strictly followed. Negative controls included reaction mixtures without DNA. A check for falsepositive and false-negative results was done by performing PCR again and then hybridizing the gels with an internal probe.
The sensitivity of the protocol used in this study was determined from experiments on CMV-infected fibroblasts; it was concluded that the sensitivity of the protocol was 1 infected cell in 105 uninfected cells.
Analysis of PCR amplification products. Amplification products were analyzed by gel electrophoresis in a 2% agarose gel (Pronarose; SphaeroQ, Leiden wells of a 96-well plate and were incubated for 2 h at 37°C in a 5% CO2 atmosphere. Then, the cultures were washed and incubated with fresh RPMI (supplemented with fetal calf serum and antibiotics) for another 2 to 3 days. Infection of the fetal fibroblasts with CMV was determined by the detection of early antigen fluorescent foci method, as follows. The cells were fixed with methanol at -20°C for 10 min. The plates were washed with phosphate-buffered saline and incubated for 2 h with a monoclonal antibody against CMV immediate-early antigen (Biosoft, Paris, France); the monoclonal antibody was diluted 1:200 in medium containing 1% albumin and 0.1% azide. The plates were washed again and incubated for another 1 h with fluorescein-conjugated goat anti-mouse IgG (Becton Dickinson, Mountain View, Calif.). Positive cultures were detected with a fluorescence microscope.
RESULTS
Comparison of antigen test and PCR. Detection of CMV antigen and detection of CMV DNA by PCR were compared for 201 samples ( Table 1) . Hybridization of the PCR products was performed on 44 samples. CMV was always detected by PCR in samples with high-level antigenemia. However, 9 of 34 samples with low-level antigenemia gave negative PCR results, whereas 54 of 156 samples negative for CMV antigen were positive by PCR. Some of the samples with inconsistent results were investigated further. This was done by hybridization of the PCR products with an internal probe and by reperforming PCR on the frozen cells of the original blood sample. Results are shown in Table 1 (see  below) . PCR was found to be positive earlier, on average, than antigenemia in patients with high numbers as well as in those with low numbers of antigen-positive cells (Table 2) . In all 13 patients in whom positive results w8ft obtained by both tests, PCR was positive earlier in eight patients, antigenemia was positive earlier in one patient, and both tests were positive at the same time in four patients. In both patient groups with highand low-level antigenemia, PCR was positive, on average, for a longer period of time than antigenemia (Table 2) .
For six patients, both the antigen test and PCR remained negative, and for five of these patients, no other evidence of CMV reactivation was seen. Two patients had a negative antigen test and a positive PCR; results for these two patients are shown separately in Table 2 . In one of these two patients, anti-CMV IgM was detected, but no other evidence for active CMV infection was present.
Retesting of PCR in discordant samples. Antigenemia was detected in nine samples from five patients, but PCR was negative (Table 1 ). All these samples had low numbers of antigen-positive cells (one or two positive cells per cytospin preparation). Eight of these samples from four patients were retested to determine whether the negative PCR could be due to sampling error. The 8 blood samples were divided into 30 samples and were again tested by PCR. Three of the eight blood samples were positive on retesting (Table 1) . "Percent of PCR-positive samples that were antigen positive. ' Percent of antigen-positive samples that were PCR positive.
Another 54 samples were positive by PCR and negative by the antigen test. Fourteen of these samples were from two patients; all of the samples from these patients were negative by the antigen test. A few samples from another three patients (27 samples) were positive by the antigen test, but nearly all samples were positive by PCR (Table 3 , groups b).
Hybridization of PCR amplification products to confirm the specificity of PCR. Hybridization of the products from PCR was done for five patients; results for two of the patients were discordant in comparison with the antigen test results (Table 1) . Hybridization results were positive for 29 PCRpositive samples, and 1 PCR-positive sample was negative by hybridization. Three of the 14 PCR-negative samples were positive by blotting. PCR, blotting, and antigen detection results for one patient are shown in Fig. 1 .
Relation between symptomatic infection and culture of buffy coat cells for the detection of viremia. Only two patients had symptomatic CMV infection; all other patients were asymptomatic. Both symptomatic patients had positive PCR results and high-level antigenemia at the time that they showed symptoms of CMV infection. Five samples were positive for culture (viremia; Inconsistent results between the detection of CMV antigen and CMV DNA were seen in samples that had low-level antigenemia and that were negative by PCR and in samples that were negative by the antigen test but positive by PCR. Some of the samples with low-level antigenemia and negative PCR results showed these results because of sampling errors and were found to be positive on retesting. Some of the inconsistent results of a positive PCR and a negative antigenemia were due to the greater sensitivity of PCR, especially for those samples from patients who were found to be positive for CMV by PCR before and after antigenemia was detected. These results confirm results of studies in bone marrow transplant recipients that indicated that PCR detects CMV DNA before antigenemia can be detected.
However, in our study, most of the discordant samples that were positive by PCR but negative for antigenemia were from five patients, most of whose samples were positive by PCR, whereas the antigen test was negative or was positive in only a few blood samples. PCR results were specific, as shown by hybridization of the PCR products from two patients. In three patients with CMV-positive cultures of urine or saliva, the higher sensitivity of PCR may explain these findings. However, in two other patients with negative antigen tests and no other evidence of CMV reactivation, there must be another explanation. Since PCR is a very sensitive technique for the detection of DNA, latent CMV DNA in minute amounts is probably detected while no significant or detectable amounts of viral antigens are present, and therefore, the antigen test is negative. Viral particles may have been phagocytosed, and the CMV DNA present in phagosomes was detected by PCR. The presence of phagocytosed CMV in granulocytes, however, has thus far been detected only during active CMV disease (6) .
In conclusion, both PCR and antigenemia are very sensitive techniques for the detection of active CMV infection; however, the correlation between CMV disease and culture of CMV from buffy coat cells is poor. 
